Sharekhan

Suraksha Diagnostic Ltd

Fri 20/02/2026,15:52:59 | NSE : SURAKSHA

₹ 281.200.80 (0.29%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 275.00

Previous Close

₹ 280.40

Volume

16608

Mkt Cap ( Rs. Cr)

₹1464.51

High

₹ 281.70

Low

₹ 275.00

52 Week High

₹ 352.50

52 Week Low

₹ 231.00

Book Value Per Share

₹ 44.24

Dividend Yield

0.00

Face Value

₹ 2.00

What’s Your Call?

Collective community sentiment on Suraksha Diagnostic Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

281.20

5

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

5

Option Chain

Analyzes market sentiment, predicts Suraksha Diagnostic Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Suraksha Diagnostic - Analysts/Institutional Investor Meet/Con. Call Updates

    12 Feb 2026, 5:10PM Suraksha Diagnostic Limited has informed the Exchange about Transcript
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    12 Feb 2026, 5:06PM Please find the enclosed transcript of the Earnings Call held on Friday, 06 February, 2026 at 02:30 pm.
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    6 Feb 2026, 5:57PM The audio recording of the Earnings Call held today, i.e. Friday, 06 February 2026 at 2.30 pm on the interaction of the Company's representative with
  • Suraksha Diagnostic - Analysts/Institutional Investor Meet/Con. Call Updates

    6 Feb 2026, 5:51PM Suraksha Diagnostic Limited has informed the Exchange about Link of Recording
  • Suraksha Diagnostic - Copy of Newspaper Publication

    6 Feb 2026, 12:22PM Suraksha Diagnostic Limited has informed the Exchange about Copy of Newspaper Publication for the unaudited (standalone and consolidated) financial re
  • Suraksha Diagnostic - Investor Presentation

    5 Feb 2026, 8:39PM Suraksha Diagnostic Limited has informed the Exchange about Investor Presentation
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Investor Presentation

    5 Feb 2026, 8:36PM Investor Presentation on the unaudited (standalone and consolidated) financial results of the Company for the quarter and nine months ended 31 Decembe
  • Suraksha Diagnostic - Press Release

    5 Feb 2026, 5:22PM Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled ""Unaudited (standalone and consolidat
  • Suraksha Diagnostic - Outcome of Board Meeting

    5 Feb 2026, 4:48PM the Financial Results for the period ended December 31, 2025.
  • Suraksha Diagnostic - Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. Thursday, 05 February 2026

    5 Feb 2026, 4:48PM With further reference to our letter dated 27 January 2026, we wish to inform you that the Board of Directors of the Company, at its meeting held toda
  • Suraksha Diagnostic Q3 net profit up 27.99% at Rs 8.14 cr

    5 Feb 2026, 5:30PM The company reported standalone net profit of Rs 8.14 crore for the quarter ended December 31, 2025 as compared to Rs 6.36 crore in the same period la
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    5 Feb 2026, 5:13PM Press release in respect of unaudited (standalone and consolidated) financial results for the quarter and nine months ended 31 December 2025
  • Suraksha Diagnostic - Financial Results Of The Company For The Quarter And Nine Months Ended 31 December 2025 Along With The

    5 Feb 2026, 4:58PM Financial Results of the Company for the quarter and nine months ended 31 December 2025 along with the Limited Review Report
  • Suraksha Diagnostic - Analysts/Institutional Investor Meet/Con. Call Updates

    29 Jan 2026, 5:05PM Suraksha Diagnostic Limited has informed the Exchange about Schedule of meet
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    29 Jan 2026, 4:52PM Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that there will be a Conf
  • Suraksha Diagnostic - Board Meeting Intimation for The Board Meeting To Be Held On Thursday, 05 February 2026

    27 Jan 2026, 11:19AM Suraksha Diagnostic Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2026 ,inter alia, to consider
  • Suraksha Diagnostic has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2025

    17 Jan 2026, 4:20PM As of December 2025, 49.00% is owned by Indian Promoters and 51.00% by Public. <p align=justify> Top five Promoters holding highest number of shares o
  • Suraksha Diagnostic - Updates

    16 Jan 2026, 5:10PM Suraksha Diagnostic Limited has informed the Exchange regarding 'Change in name of Statutory Auditor of the Company pursuant to conversion into LLP'.
  • Suraksha Diagnostic - Intimation Regarding Change In Name Of Statutory Auditor Of The Company Pursuant To Conversion Into LLP

    16 Jan 2026, 5:05PM The Statutory Auditor of the Company informed the Company about the change in the name of the audit firm from M S K A & Associates to M S K A & Associ
  • Suraksha Diagnostic - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    12 Jan 2026, 10:53AM Suraksha Diagnostic Limited has informed the Exchange about Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 20
  • Suraksha Diagnostic - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    12 Jan 2026, 10:32AM Compliance Certificate from our RTA i.e. KFin Technologies Limited under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018
  • Suraksha Diagnostic - Trading Window

    22 Dec 2025, 10:10AM Suraksha Diagnostic Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulatio
  • Suraksha Diagnostic - Analysts/Institutional Investor Meet/Con. Call Updates

    8 Dec 2025, 9:38AM Suraksha Diagnostic Limited has informed the Exchange about the revised mode of the Analyst or Investor meet
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    8 Dec 2025, 9:31AM Intimation for revision of the mode of Analyst / Investor Meet
  • Suraksha Diagnostic - Analysts/Institutional Investor Meet/Con. Call Updates

    2 Dec 2025, 3:40PM Suraksha Diagnostic Limited has informed the Exchange about Schedule of meet
  • Suraksha Diagnostic - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    2 Dec 2025, 3:29PM Intimation of Schedule of Analysts / Institutional Investors / Organisations meet

Key fundamentals

Evaluate the intrinsic value of Suraksha Diagnostic Ltd stock 

Name March-25 March-24 March-23 March-22
Assets 220.1374 189.5015 170.6301 169.0335
Liabilities 220.1374 189.5015 170.6301 169.0335
Equity 10.4162 6.9 6.9 6.9
Gross Profit 82.5903 71.1917 44.9867 47.5072
Net Profit 33.44 24.3839 7.189 23.751
Cash From Operating Activities 62.798 61.23 44.9253 42.3306
NPM(%) 13.42 11.15 3.78 10.64
Revenue 249.0954 218.5247 189.9854 223.1925
Expenses 166.5051 147.333 144.9987 175.6853
ROE(%) 14.51 10.58 3.12 10.3

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Suraksha Diagnostic Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 725.70 0.24 43.09 160.91 301.39 0.69
Lotus Eye Hospital and Institute Ltd 117.51 -5.00 379.06 586.35 3.55 0.00
Vaishali Pharma Ltd 7.73 -0.64 0.00 3678.38 3.13 0.00
Astec Lifesciences Ltd 633.05 -0.99 0.00 552.94 -604.77 0.00

Company Info

The Company was incorporated as `Suraksha Diagnostic Private Limited' as a private limited company under the Companies Act, 1956 pursuant to a certificate of incorporation dated March 15, 2005, issued by the Deputy Registrar of Companies, West Bengal at Kolkata ("RoC"). Subsequently, our Company was converted into a public limited company pursuant to a special resolution passed in the extra-ordinary general meeting of our Shareholders held on June 5, 2024, and consequently, the name of our Company was changed to `Suraksha Diagnostic Limited', and a fresh certificate of incorporation dated July 16, 2024, was issued by the Registrar of Companies, Central Processing Centre.Major Events and Milestones:2007-Launched the first centre of the Company at Kestopur, West Bengal.2010-Launched centre at Khardah, West Bengal and number of operating centres increased to 5.2013-Received first round of funding of Rs.300 million from private equity investor Lighthouse Funds, through their investment entity India 2020 Limited.2016-Number of laboratories increased to 4 and number of operating centres increased to 25.-Received second round of funding of Rs.200 million from OrbiMed Asia II Mauritius FDI Investments Limited (since amalgamated into OrbiMed Asia II Mauritius Limited), and also marked the exit of the India 2020 Limited from the Company.2017-Acquired the business of Sunwell Diagnostic Private Limited for a consideration of Rs.30 million.2019-Expansion of our operations to Meghalaya through a public-private partnership with the Government of Meghalaya.2020-Acquisition of 2 pre-existing diagnostic centres in Kolkata from Future Medical and Research Trust for a consideration of Rs.67 million.2023-Established our first 3T MRI and 128 CT at New Town

The Company was incorporated as `Suraksha Diagnostic Private Limited' as a private limited company under the Companies Act, 1956 pursuant to a certificate of incorporation dated March 15, 2005, issued by the Deputy Registrar of Companies, West Bengal at Kolkata ("RoC"). Subsequently, our Company was converted into a public limited company pursuant to a special resolution passed in the extra-ordinary general meeting of our Shareholders held on June 5, 2024, and consequently, the name of our Company was changed to `Suraksha Diagnostic Limited', and a fresh certificate of incorporation dated July 16, 2024, was issued by the Registrar of Companies, Central Processing Centre.Major Events and Milestones:2007-Launched the first centre of the Company at Kestopur, West Bengal.2010-Launched centre at Khardah, West Bengal and number of operating centres increased to 5.2013-Received first round of funding of Rs.300 million from private equity investor Lighthouse Funds, through their investment entity India 2020 Limited.2016-Number of laboratories increased to 4 and number of operating centres increased to 25.-Received second round of funding of Rs.200 million from OrbiMed Asia II Mauritius FDI Investments Limited (since amalgamated into OrbiMed Asia II Mauritius Limited), and also marked the exit of the India 2020 Limited from the Company.2017-Acquired the business of Sunwell Diagnostic Private Limited for a consideration of Rs.30 million.2019-Expansion of our operations to Meghalaya through a public-private partnership with the Government of Meghalaya.2020-Acquisition of 2 pre-existing diagnostic centres in Kolkata from Future Medical and Research Trust for a consideration of Rs.67 million.2023-Established our first 3T MRI and 128 CT at New Town

Read More

Parent Organisation

Suraksha Diagnostic Ltd.

Founded

15/03/2005

Managing Director

Ms.Ritu Mittal

NSE Symbol

SURAKSHAEQ

FAQ

The current price of Suraksha Diagnostic Ltd is ₹ 281.20.

The 52-week high for Suraksha Diagnostic Ltd is ₹ 281.70 and the 52-week low is ₹ 275.00.

The market capitalization of Suraksha Diagnostic Ltd is currently ₹ 1464.51. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Suraksha Diagnostic Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Suraksha Diagnostic Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Suraksha Diagnostic Ltd shares.

The CEO of Suraksha Diagnostic Ltd is Ms.Ritu Mittal, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT